US Stock MarketDetailed Quotes

CHRO Chromocell Therapeutics

Watchlist
  • 1.420
  • -0.060-4.05%
Close Jun 7 16:00 ET
  • 1.420
  • 0.0000.00%
Post 16:02 ET
8.19MMarket Cap-910P/E (TTM)

Chromocell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
111.46%1.93M
196.02%6.86M
219.29%3.88M
148.96%1.29M
161.97%777.16K
217.73%914.58K
176.30%2.32M
478.57%1.21M
518.84K
296.66K
Selling and administrative expenses
101.43%1.47M
122.32%4.28M
72.20%1.58M
153.15%1.24M
169.25%727.21K
197.03%728.47K
205.81%1.93M
513.86%920.23K
--490.86K
--270.08K
-General and administrative expense
101.43%1.47M
122.32%4.28M
72.20%1.58M
153.15%1.24M
169.25%727.21K
197.03%728.47K
205.81%1.93M
513.86%920.23K
--490.86K
--270.08K
Research and development costs
150.71%466.61K
558.47%2.58M
678.80%2.29M
75.59%49.13K
87.99%49.96K
336.97%186.12K
87.39%391.73K
390.50%294.58K
--27.98K
--26.57K
Operating profit
-111.46%-1.93M
-196.02%-6.86M
-219.29%-3.88M
-148.96%-1.29M
-161.97%-777.16K
-217.73%-914.58K
-176.30%-2.32M
-478.57%-1.21M
-518.84K
-296.66K
Net non-operating interest income expense
-1,108.87%-628.35K
-269.23%-518.51K
-276.27%-160.34K
-243.82%-130.01K
-371.08%-176.19K
-129.94%-51.98K
-55,405.93%-140.43K
-42.61K
-37.81K
-37.4K
Non-operating interest expense
1,108.87%628.35K
269.23%518.51K
276.27%160.34K
243.82%130.01K
371.08%176.19K
129.94%51.98K
55,405.93%140.43K
--42.61K
--37.81K
--37.4K
Other net income (expense)
Income before tax
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
-556.66K
-334.06K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
-556.66K
-334.06K
Net income continuous Operations
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
---556.66K
---334.06K
Minority interest income
Net income attributable to the parent company
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
-556.66K
-334.06K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
-556.66K
-334.06K
Basic earnings per share
-428.45%-0.55
-383.39%-1.2797
-417.24%-0.7003
-311.25%-0.2465
-359.53%-0.1653
-246.93%-0.1041
-156.45%-0.2647
-498.87%-0.1354
-0.0599
-0.036
Diluted earnings per share
-428.45%-0.55
-383.39%-1.2797
-417.24%-0.7003
-311.25%-0.2465
-359.53%-0.1653
-246.93%-0.1041
-156.45%-0.2647
-498.87%-0.1354
-0.0599
-0.036
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 111.46%1.93M196.02%6.86M219.29%3.88M148.96%1.29M161.97%777.16K217.73%914.58K176.30%2.32M478.57%1.21M518.84K296.66K
Selling and administrative expenses 101.43%1.47M122.32%4.28M72.20%1.58M153.15%1.24M169.25%727.21K197.03%728.47K205.81%1.93M513.86%920.23K--490.86K--270.08K
-General and administrative expense 101.43%1.47M122.32%4.28M72.20%1.58M153.15%1.24M169.25%727.21K197.03%728.47K205.81%1.93M513.86%920.23K--490.86K--270.08K
Research and development costs 150.71%466.61K558.47%2.58M678.80%2.29M75.59%49.13K87.99%49.96K336.97%186.12K87.39%391.73K390.50%294.58K--27.98K--26.57K
Operating profit -111.46%-1.93M-196.02%-6.86M-219.29%-3.88M-148.96%-1.29M-161.97%-777.16K-217.73%-914.58K-176.30%-2.32M-478.57%-1.21M-518.84K-296.66K
Net non-operating interest income expense -1,108.87%-628.35K-269.23%-518.51K-276.27%-160.34K-243.82%-130.01K-371.08%-176.19K-129.94%-51.98K-55,405.93%-140.43K-42.61K-37.81K-37.4K
Non-operating interest expense 1,108.87%628.35K269.23%518.51K276.27%160.34K243.82%130.01K371.08%176.19K129.94%51.98K55,405.93%140.43K--42.61K--37.81K--37.4K
Other net income (expense)
Income before tax -165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M-556.66K-334.06K
Income tax 0000000000
Net income -165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M-556.66K-334.06K
Net income continuous Operations -165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M---556.66K---334.06K
Minority interest income
Net income attributable to the parent company -165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M-556.66K-334.06K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M-556.66K-334.06K
Basic earnings per share -428.45%-0.55-383.39%-1.2797-417.24%-0.7003-311.25%-0.2465-359.53%-0.1653-246.93%-0.1041-156.45%-0.2647-498.87%-0.1354-0.0599-0.036
Diluted earnings per share -428.45%-0.55-383.39%-1.2797-417.24%-0.7003-311.25%-0.2465-359.53%-0.1653-246.93%-0.1041-156.45%-0.2647-498.87%-0.1354-0.0599-0.036
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Recent IPOs
Recent IPOs
Intraday-0.32%